Document:

EX-10.16

 

Exhibit 10.16

Conformed Copy

WebMD Health Holdings, Inc.

111 Eighth Avenue

New York, NY 10001

July 14, 2005

Nan-Kirsten Forte

c/o WebMD Health Holdings, Inc.

111 Eighth Avenue

New York, NY 10001

Dear Nan:

     This letter confirms the terms of your employment with WebMD Health Holdings, Inc. (the
“Company” or “WebMD Health”), a subsidiary of WebMD Corporation, and amends and supersedes in its
entirety the Letter Agreement dated September 12, 2000 between you and WebMD Corporation and the
Employment Agreement between you and Greenberg News Networks, Inc. (collectively, the “Prior
Agreements”).

     1. Position and Responsibilities. As of the Effective Date (as defined below), you
will serve in the position of Executive Vice President- Consumer Services of WebMD Health. You
will report to the CEO of WebMD Health, the EVP Products and Programming of WebMD Health or such
other executive officer as the Chief Executive Officer may designate and will assume and discharge
such responsibilities as are commensurate with such position as such person may direct. During
your employment with the Company, you will devote your full business time to your duties and
responsibilities and will perform them faithfully and diligently in accordance with the terms of
this Agreement, subject to permitted absence in accordance with the Company’s vacation policy. In
addition, you will comply with and be bound by the operating policies, procedures and practices of
the Company including, without limitation, the Code of Conduct, in effect from time to time during
your employment. You will report to the Company’s headquarters located in New York, NY. You
acknowledge that you will be required to travel in connection with the performance of your duties
but you will not be required to relocate outside the New York metropolitan area without your
consent.

     2. Compensation.

     (a) In consideration of your services, you will be paid a base salary (“Base Salary”) at the
annual rate of $352,500, payable in accordance with the Company’s prevailing payroll practices.

     (b) You will be eligible to receive an annual bonus, the target of which is 35% of Base
Salary, so long as you are employed by the Company on the applicable payment date, except as set
forth below. The determination as to the amount of such bonus shall be made by the WebMD Health
Compensation Committee (as defined in Section 5(a) below) in its sole
discretion. Subject to Section 6 below, if your employment is terminated following the end of

 

 

any fiscal year by the Company without Cause or by you for Good Reason (as defined below), then you
will still be entitled to receive any bonus otherwise payable to you for such year, even if you are
not employed on the bonus payment date and such bonus will be paid at the time that bonuses are
paid to other executives of the Company.

     3. Other Benefits. You will continue to be entitled to receive the standard employee
benefits made available by the Company to its employees to the full extent of your eligibility.
You will be entitled to vacation consistent with the Company’s vacation policy. During your
employment, you will be permitted, to the extent eligible, to participate in any group medical,
dental, life insurance and disability insurance plans, or similar benefit plan of the Company that
is available to employees generally. Participation in any such plan will be consistent with your
rate of compensation to the extent that compensation is a determinative factor with respect to
coverage under any such plan. The Company will reimburse you for all reasonable expenses actually
incurred or paid by you in the performance of your services on behalf of the Company, upon prior
authorization and approval in accordance with the Company’s expense reimbursement policy as from
time to time in effect.

     4. WebMD Corporation Equity Grants.

	 	(a)	 	The options to purchase WebMD Corporation common stock and the shares of
restricted stock of WebMD Corporation previously granted to you will remain outstanding
in accordance with the terms of the applicable Stock Plan and the award agreement.
	 
	 	(b)	 	For the avoidance of doubt, in the event there is a transaction which results
in WebMD Health no longer being a Subsidiary (as defined in the applicable stock plan)
of WebMD Corporation (e.g., a complete spinoff of WebMD Health), the options to
purchase WebMD Corporation common stock, to the extent not vested, would be forfeited
and the vested portion of such options will remain outstanding for the post termination
exercise period specified in the applicable option agreement. The restricted stock of
WebMD Corporation would, to the extent not vested, be forfeited.

     5. WebMD Health Equity. As you are aware, the Company has filed a Form S-1
Registration Statement which contemplates a transaction whereby a portion of the securities of
WebMD Health would be registered pursuant to the Securities Act of 1933 and be publicly traded (the
“Offering”). Although there can be no assurance that the Offering will occur, we are working
diligently towards that goal.

	 	(a)	 	In the event of the consummation of the Offering, the Company will recommend to
the Compensation Committee of the Board of Directors of the Company (the “WebMD
Health Compensation Committee”) that you be granted a nonqualified option (the
“New Stock Option”) to purchase 200,000 shares of the Company’s common stock.
The New Stock Option grant assumes a capitalization of 100 million shares outstanding
(on a fully diluted basis) upon the consummation of the Offering. The number of shares
corresponding to the New Stock Option will be
adjusted proportionately upward or downward in the event the capitalization of 

 

 

	 	 	 	the Company upon the consummation of the Offering is greater or less than the 100
million shares assumed above. The New Stock Option will be at an exercise price
equal to the fair market value of the Company’s common stock (as determined by the
WebMD Health Compensation Committee) on the Effective Date determined in the same
manner and at the same price as granted to other senior executives of the Company.
The New Stock Option will be granted pursuant to the terms of a stock option plan
and a stock option agreement to be entered into between you and the Company, which
agreement will be in substantially the same form provided by the Company to its
employees generally. The New Stock Option will vest and become exercisable, subject
to your continued employment with the Company on such dates (except as provided in
Section 6 below) in accordance with the following schedule: 25% will vest on the
first anniversary of the Effective Date and 25% will vest on each of the subsequent
three anniversaries of the Effective Date.

	 	(b)	 	In the event of the consummation of the Offering, the Company will recommend
to the WebMD Health Compensation Committee that Executive be granted 50,000 shares of
restricted stock of the Company on the Effective Date (the “New Restricted Stock”),
subject to proportionate adjustment in the number of New Restricted Stock as provided
in Section 5(a) above. The New Restricted Stock will vest and the restrictions
thereon lapse in equal annual installments over four years, commencing on the first
anniversary of the date of grant subject to your continued employment on the
applicable dates. The Restricted Stock will be subject to the terms of a stock plan
and a restricted stock agreement to be entered into between you and the Company, which
agreement will be in substantially the same form provided by the Company to its
employees generally.

     6. Termination of Employment. In the event of the termination of your employment by
the Company without Cause or by you for Good Reason (as such terms are defined on Annex A attached
hereto) prior- to the fourth anniversary of the Effective Date, you will be entitled to
(i) continue to receive, as severance, the Base Salary in effect on the date hereof for a period of
one year (the “Severance Period”), (ii) any bonus payable under the last sentence in Section 2(b)
above, and (iii) if you timely elect to continue your health coverage through COBRA, the Company
will pay that portion of the COBRA premium that it would pay if you were an active employee with
the same type of coverage through the Severance Period or, if earlier, until you are eligible for
comparable coverage with a subsequent employer, subject to your execution of a release satisfactory
to the Company (but which will not require release of any Company payments due to you that are
otherwise payable at the date of termination of this Agreement) and your continued compliance with
the Trade Secret & Proprietary Information Agreement. In addition, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason prior to the fourth
anniversary of the Effective Date, 25% of the New Stock Option (if granted) will continue to vest
and remain outstanding as if you remained in the employ of the Company through the vesting date
following the date of termination, subject to your execution of a release satisfactory to the
Company and your continued compliance with the Trade Secret & Proprietary Information Agreement. In
the event of termination of your employment for any other reason, you will receive compensation
earned through the date of

 

 

termination and your rights with respect to options and restricted stock will be as specified
in the applicable option or restricted stock agreements.

     7. Restrictive Covenants. You agree that the effectiveness of this Agreement is
contingent upon your execution of, and delivery to the Company of Trade Secret & Proprietary
Information Agreement in the form attached hereto as Annex B.

     8. Conflicting Employment. You agree that, during your employment with the Company,
you will not engage in any other employment, occupation, consulting or other business activity
directly related to the business in which the Company is now involved or becomes involved during
your employment, nor will you engage in any other activities that conflict with your obligations to
the Company. With the prior written approval of the Company, which will not be unreasonably
withheld, you may serve on the Board of Directors of other companies, and provided that such
service does not affect the services to be provided under this Agreement.

     9. At-Will Employment. You acknowledge that your employment with the Company is for an
unspecified duration that constitutes at-will employment, and that either you or the Company can
terminate this relationship at any time, with or without Cause and with or without notice (subject
to the consequences set forth in this agreement).

     10. Effective Date. This Agreement will become effective as of the effectiveness of
the Offering (the “Effective Date”). In the event that the Offering does not occur, this
Agreement will be null and void and will have no force and effect, including, without limitation,
the obligations under Section 5.

11. General Provisions.

	 	(a)	 	You will be covered by the Company’s director and officer insurance policy to
the same extent as other similarly situated employees of the Company.
	 
	 	(b)	 	This letter agreement and the terms of your employment will be governed by the
laws of New York, applicable to agreements made and to be performed entirely within
such state, and the courts sitting in New York, New York shall have exclusive
jurisdiction for the purposes of adjudicating any disputes under this Agreement.
	 
	 	(c)	 	This letter agreement together with the equity plans and agreements referred to
herein and the Trade Secret and Proprietary Agreement attached hereto sets forth the
entire agreement and understanding between the Company and you relating to your
employment and supersedes all prior verbal discussions between us and the Prior
Agreements.
	 
	 	(d)	 	This agreement will be binding upon your heirs, executors, administrators and
other legal representatives and will be for the benefit of the Company and its
permitted successors and assigns

 

 

	 	(e)	 	All payments pursuant to this letter will be subject to applicable withholding
taxes.
	 
	 	(f)	 	This agreement may not be assigned by the Company without your prior written
consent; provided however that this agreement may be assigned by the Company without
your prior written consent to any successor to the business of the Company, by
operation of law, merger or otherwise or to any affiliate of the Company.

     Please acknowledge and confirm your acceptance of this letter by, signing and returning one
copy of this letter agreement and the Trade Secret & Proprietary Information Agreement to Douglas
W. Wamsley, Executive Vice President, General Counsel, WebMD Health Holdings, Inc., 111 Eighth
Avenue, New York, NY 10001.

WebMD Health Holdings, Inc.

By /s/
Douglas W. Wamsley

 

ACCEPTANCE:

     I accept the revised terms of my employment with WebMD Health Holdings, Inc. as set forth
herein. I understand that this letter agreement does not constitute a contract of employment for
any specified period of time, and that either party, with or without Cause and with or without
notice, may terminate my employment relationship (subject to the consequences set forth above).

/s/ Nan Kirsten Forte

 

     Nan Kirsten Forte

8/19/05

 

     Date Signed

 

 

ANNEX A

“Cause” will mean any of the following:

     (i) your willful failure to perform your duties following written notice from the Company
detailing the specific acts and a thirty (30) day period of time to remedy such failure;

     (ii) any willful misconduct, violence or threat of violence that is injurious to the Company
in a material respect or any misconduct relating to your business affairs, at any time, which will
demonstrably reflect negatively upon the Company or otherwise impair or impede its operations or
reputation in any material respect;

     (iii) your breach of a material Company policy, which breach is not remedied (if susceptible
to remedy) following written notice by the Company detailing the specific breach and a thirty (30)
day period of time to remedy such breach;

     (iv) any material breach by you of this Agreement or the Trade Secret and Proprietary
Information Agreement, which breach is not remedied (if susceptible to remedy) following written
notice by the Company or its designee detailing the specific breach and a thirty (30) day period of
time to remedy such breach;

     (v) your conviction of a felony in respect of a dishonest or fraudulent act or other crime of
moral turpitude.

     “Good Reason” means any of the following conditions or events that remain in effect 30
days after written notice is provided by you to the Company detailing such condition or event (i)
any reduction in your base salary, (ii) a material reduction in your authority with the Company,
and (iii) any material breach by the Company of this Agreement.

 

 

ANNEX B

TRADE SECRET AND PROPRIETARY INFORMATION AGREEMENT

     In consideration of WebMD Health Holdings, Inc. (hereinafter referred to as the “Company”)
entering into the Letter Agreement dated July 14, 2005, I hereby agree as follows:

     1. Confidentiality.

          (a) Trade Secret and Proprietary Information. I understand and acknowledge that,
during the course of my employment arrangement with the Company and as a result of my having
executed this Trade Secret and Proprietary Information Agreement, I will be granted access to
valuable information relating to the Company’s Business (as defined below) that provides the
Company with a competitive advantage, which is not generally known by, nor easily learned or
determined by, persons outside the Company (collectively “Trade Secret an Proprietary
Information”). The term Trade Secret and Proprietary Information will include, but will not be
limited to: (a) specifications, manuals, software in various stages of development; (b) customer
and prospect lists, and details of agreements and communications with customers and prospects; (c)
sales plans and projections, product pricing information, acquisition, expansion, marketing,
financial and other business information and existing and future products and business plans of the
Company; (d) sales proposals, demonstrations systems, sales material; (e) research and development;
(f) computer programs, (g) sources of supply; (h) identity of specialized consultants and
contractors and Trade Secret and Proprietary Information developed by them for the Company; (i)
purchasing, operating and other cost data; (j) special customer needs, cost and pricing data; (k)
patient information; including without limitation Protected Health Information as defined in 45
C.F.R. 164.501 and (l) employee information (including, but not limited to, personnel, payroll,
compensation and benefit data and plans), including all such information recorded in manuals,
memoranda, projections, reports, minutes, plans, drawings, sketches, designs, formula books, data,
specifications, software programs and records, whether or not legended or otherwise identified by
the Company as Trade Secret and Proprietary Information, as well as such information that is the
subject of meetings and discussions and not recorded. Trade Secret and Proprietary Information
will not include such information that I can demonstrate (i) is generally available to the public
(other than as a result of a disclosure by me), (ii) was disclosed to me by a third party under no
obligation to keep such information confidential or (iii) was known by me prior to, and not as a
result of, my employment or anticipated employment with the Company or any of its Affiliates.

          (b) Duty of Confidentiality. I agree at all times, both during and after my employment
with the Company, to hold all of the Company’s Trade Secret and Proprietary Information in a
fiduciary capacity for the benefit of the Company and to safeguard all such Trade Secret and
Proprietary Information. I also agree that I will not directly or indirectly disclose or use any
such Trade Secret and Proprietary Information to any third person or entity outside the Company,
except as may be necessary in the good faith performance of my duties for the Company. I further
agree that, in addition to enforcing this restriction, the Company may have other rights and
remedies under the common law or applicable statutory laws relating to the protection of trade
secrets. Notwithstanding anything in this Agreement to the contrary, I

 

 

understand that I may disclose the Company’s Trade Secret and Proprietary Information to the
extent required by applicable laws or governmental regulations or judicial or regulatory process,
provided that I give the Company prompt notice of any and all such requests for disclosure so that
it has ample opportunity to take all necessary or desired action, to avoid disclosure.

     (c) Unfair Competition. I acknowledge that the Company has a compelling business
interest in preventing unfair competition stemming from the intentional or inadvertent use or
disclosure of the Company’s Trade Secret and Proprietary Information and Company Property.

     (d) Intellectual Property and Inventions. I acknowledge that all developments,
including, without limitation, the creation of new products, conferences, training/seminars,
publications, programs, methods of organizing information, inventions, discoveries, concepts,
ideas, improvements, patents, trademarks, trade names, copyrights, trade secrets, designs, works,
reports, computer software, flow charts, diagrams, procedures, data, documentation, and writings
and applications thereof relating to the past, present, or future business of the Company that I,
alone or jointly with others, may have discovered, conceived, created, made, developed, reduced to
practice, or acquired during my employment with the Company (collectively, “Developments”) are
works made for hire and will remain the sole and exclusive property of the Company, and I hereby
assign to the Company all of my rights, titles, and interest in and to all such Developments, if
any. I agree to disclose to the Company promptly and fully all future Developments and, at any time
upon request and at the expense of the Company, to execute, acknowledge, and deliver to the Company
all instruments that the Company will prepare, to give evidence, and to take any and all other
actions that are necessary or desirable in the reasonable opinion of the Company to enable the
Company to file and prosecute applications for, and to acquire, maintain, and enforce, all letters
patent, trademark registrations, or copyrights covering the Developments in all countries in which
the same are deemed necessary by the Company. All data, memoranda, notes, lists, drawings,
records, files, investor and client/customer lists, supplier lists, and other documentation (and
all copies thereof) made or compiled by me or made available to me concerning the Developments or
otherwise concerning the past, present, or planned business of the Company are the property of the
Company, and will be delivered to the Company immediately upon the termination of my employment
with the Company.

     (e) Competitive Business. For purposes of this Agreement “Competitive Business” will
mean: (i) any enterprise engaged in developing, selling or providing a consumer or physician
Internet healthcare portal or interactive online personal health management products; and (ii) any
enterprise engaged in any other type of business in which the Company or one of its Affiliates is
also engaged, or plans to be engaged, so long as I am directly involved in such business or planned
business on behalf of the Company or one of its Affiliates.

     2. Non-Solicitation of Employees, Customers. In order to protect the Company’s Trade
Secret and Proprietary Information;

     (i) during my employment with the Company and for a period of one year after the termination
of such employment for any reason (the “Restricted Period”), I will not, without the Company’s
express written permission, directly or indirectly solicit, induce, hire, engage, or attempt to
hire or engage any employee or independent contractor of the Company, or in any other way interfere
with the Company’s employment or contractual relations with any of its

 

 

employees or independent contractors, nor will I solicit, induce, hire, engage or attempt to
hire or engage any individual who was an employee of the Company at any time during the one year
period immediately prior to the termination of my employment with the Company

     (ii) during the Restricted Period, I will not, without the Company’s express written
permission, directly or indirectly contact, call upon or solicit, on behalf of a Competitive
Business, any existing or prospective client, or customer of the Company who I serviced, or
otherwise developed a relationship with, as a result of my employment with the Company, nor will I
attempt to divert or take away from the Company the business of any such client or customer.

     3. Restrictions on Competitive Employment. In order to protect the Company’s Trade
Secret and Proprietary Information, during the Restricted Period, I will not (as principal, agent,
employee, consultant, director or otherwise), anywhere in the United States and Canada, directly or
indirectly, without the prior written approval of the Company, engage in, or perform any services
for, a Competitive Business. Notwithstanding the foregoing, I understand that I may have an
interest consisting of publicly traded securities constituting less than 1 percent of any class of
publicly traded securities in any public company engaged in a Competitive Business so long as I am
not employed by and do not consult with, or become a director of or otherwise engage in any
activities for, such company. The Restricted Period will be extended by the length of any period
during which I am in breach of the terms of this paragraph.

     4. Injunctive Remedies. I acknowledge and agree that the restrictions contained in
this Agreement are reasonably necessary to protect the legitimate business interests of the
Company, and that any violation of any of the restrictions will result in immediate and irreparable
injury to the Company for which monetary damages will not be an adequate remedy. I further
acknowledge and agree that if any such restriction is violated, the Company will be entitled to
immediate relief enjoining such violation (including, without limitation, temporary and permanent
injunctions, a decree for specific performance, and an equitable accounting of earnings, profits,
and other benefits arising from such violation) in any court having jurisdiction over such claim,
without the necessity of showing any actual damage or posting any bond or furnishing any other
security, and that the specific enforcement of the provisions of this Agreement will not diminish
my ability to earn a livelihood or create or impose upon me any undue hardship. I also agree that
any request for such relief by the Company will be in addition to, and without prejudice to, any
claim for monetary damages that the Company may elect to assert.

     5. Severability Provision. I acknowledge and agree that the restrictions imposed upon
me by the terms, conditions, and provisions of this Agreement are fair, reasonable, and reasonably
required for the protection of the Company. In the event that any part of this Agreement is deemed
invalid, illegal, or unenforceable, all other terms, conditions, and provisions of this Agreement
will nevertheless remain in full force and effect. In the event that the provisions of any of
Sections l, 2, or 3 of this Agreement relating to the geographic area of restriction, the length of
restriction or the scope of restriction will be deemed to exceed the maximum area, length or scope
that a court of competent jurisdiction would deem enforceable, said area, length or scope will, for
purposes of this Agreement, be deemed to be the maximum area, length of time or scope that such
court would deem valid and enforceable, and that such

 

 

court has the authority under this Agreement to rewrite (or “blue-pencil”) the restriction(s)
at-issue to achieve this intent.

     6. Non-Waiver. Any waiver by the Company of my breach of any term, condition, or
provision of this Agreement will not operate or be construed as a waiver of the Company’s rights
upon any subsequent breach.

     7. Waiver of Jury Trial. TO THE MAXIMUM EXTENT PERMITTED BY LAW, I HEREBY KNOWINGLY,
VOLUNTARILY, AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN CONNECTION WITH ANY LITIGATION
ARISING OUT OF, UNDER, IN CONNECTION WITH, OR IN ANY WAY RELATED TO THIS AGREEMENT. THIS INCLUDES,
WITHOUT LIMITATION, ANY LITIGATION CONCERNING ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENT
(WHETHER VERBAL OR WRITTEN), OR ACTION OF THE COMPANY OR ME, OR ANY EXERCISE BY THE COMPANY OR ME
OF OUR RESPECTIVE RIGHTS UNDER THIS AGREEMENT OR IN ANY WAY RELATING TO THIS AGREEMENT. I FURTHER
ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE COMPANY TO ISSUE AND ACCEPT THIS
AGREEMENT.

     8. Continuation of Employment. This Agreement does not constitute a contract of
employment or an implied promise to continue my employment or status with the Company; nor does
this agreement affect my rights or the rights of the Company to terminate my employment status at
any time with or without cause (subject to the consequences set forth in the Agreement to which
this Annex is attached).

     9. Governing Law. This Agreement will be construed in accordance with and governed
for all purposes by the laws and public policy of the State of New York, without regard to
principles of conflict of laws.

/S/ Nan Kirsten Forte 

Nan Kirsten Forte

/S/
Douglas W. Wamsley 

Witness

8/19/05 

Date

Address:
111 Eighth Ave, NY, NY, 10011EX-10.17

 

Exhibit 10.17

Conformed Copy

WebMD Health Holdings, Inc.

111 Eighth Avenue

New York, NY 10001

July 14, 2005

Steven Zatz

c/o WebMD Health Holdings, Inc.

111 Eighth Avenue

New York, NY 10001

Dear Steve:

     This letter confirms the terms of your employment with WebMD Health Holdings, Inc. (the
“Company” or “WebMD Health”), a subsidiary of WebMD Corporation, and amends and supersedes in its
entirety the Employment Agreement dated October 4, 2000 between you and WebMD Corporation (the
“Prior Agreement”).

     1. Position and Responsibilities. As of the Effective Date (as defined below), you
will serve in the position of Executive Vice President- Professional Services of WebMD Health. You
will report to the CEO of WebMD Health or such other executive officer as the Company may designate
and will assume and discharge such responsibilities as are commensurate with such position as such
person may direct. During your employment with the Company, you will devote your full business
time to your duties and responsibilities and will perform them faithfully and diligently in
accordance with the terms of this Agreement, subject to permitted absence in accordance with the
Company’s vacation policy. In addition, you will comply with and be bound by the operating
policies, procedures and practices of the Company including, without limitation, the Code of
Conduct, in effect from time to time during your employment. You will report to the Company’s
headquarters located in New York, NY. You acknowledge that you will be required to travel in
connection with the performance of your duties but you will not be required to relocate outside the
New York metropolitan area without your consent.

     2. Compensation.

     (a) In consideration of your services, you will be paid a base salary (“Base Salary”) at the
annual rate of $345,000, payable in accordance with the Company’s prevailing payroll practices.

     (b) You will be eligible to receive an annual bonus, the target of which is 35% of Base
Salary, so long as you are employed by the Company on the applicable payment date, except as set
forth below. The determination as to the amount of such bonus shall be made by the WebMD Health
Compensation Committee (as defined in Section 5(a) below) in its sole discretion. Subject to
Section 6 below, if your employment is terminated following the end of any fiscal year by the
Company without Cause or by you for Good Reason (as defined below), then you will still be entitled
to receive any bonus otherwise payable to you for such year, even if

 

 

you are not employed on the bonus payment date and such bonus will be paid at the time that
bonuses are paid to other executives of the Company.

     3. Other Benefits. You will continue to be entitled to receive the standard employee
benefits made available by the Company to its employees to the full extent of your eligibility.
You will be entitled to vacation consistent with the Company’s vacation policy. During your
employment, you will be permitted, to the extent eligible, to participate in any group medical,
dental, life insurance and disability insurance plans, or similar benefit plan of the Company that
is available to employees generally. Participation in any such plan will be consistent with your
rate of compensation to the extent that compensation is a determinative factor with respect to
coverage under any such plan. The Company will reimburse you for all reasonable expenses actually
incurred or paid by you in the performance of your services on behalf of the Company, upon prior
authorization and approval in accordance with the Company’s expense reimbursement policy as from
time to time in effect.

4. WebMD Corporation Equity Grants.

	 	(a)	 	The options to purchase WebMD Corporation common stock and the shares of
restricted stock of WebMD Corporation previously granted to you will remain outstanding
in accordance with the terms of the applicable Stock Plan and the award agreement.
	 
	 	(b)	 	For the avoidance of doubt, in the event there is a transaction which results
in WebMD Health no longer being a Subsidiary (as defined in the applicable Stock Plan)
of WebMD Corporation (e.g., a complete spinoff of WebMD Health), the options to
purchase WebMD Corporation common stock, to the extent not vested, would be forfeited
and the vested portion of such options will remain outstanding for the post termination
exercise period specified in the applicable option agreement. The restricted stock of
WebMD Corporation would, to the extent not vested, be forfeited.

     5. WebMD Health Equity. As you are aware, the Company has filed a Form S-1
Registration Statement which contemplates a transaction whereby a portion of the securities of
WebMD Health would be registered pursuant to the Securities Act of 1933 and be publicly traded (the
“Offering”). Although there can be no assurance that the Offering will occur, we are working
diligently towards that goal.

	 	(a)	 	In the event of the consummation of the Offering, the Company will recommend to
the Compensation Committee of the Board of Directors of the Company (the “WebMD
Health Compensation Committee”) that you be granted a nonqualified option (the
“New Stock Option”) to purchase 160,000 shares of the Company’s common stock.
The New Stock Option grant assumes a capitalization of 100 million shares outstanding
(on a fully diluted basis) upon the consummation of the Offering. The number of shares
corresponding to the New Stock Option will be adjusted proportionately upward or
downward in the event the capitalization of the Company upon the consummation of the
Offering is greater or less than the 100 million shares assumed above. The New Stock
Option will be at an exercise

 

 

	 	 	 	price equal to the fair market value of the Company’s common stock (as determined by
the WebMD Health Compensation Committee) on the Effective Date determined in the
same manner and at the same price as granted to other senior executives of the
Company. The New Stock Option will be granted pursuant to the terms of a stock
option plan and a stock option agreement to be entered into between you and the
Company, which agreement will be in substantially the same form provided by the
Company to its employees generally. The New Stock Option will vest and become
exercisable, subject to your continued employment with the Company on such dates
(except as provided in Section 6 below) in accordance with the following schedule:
25% will vest on the first anniversary of the Effective Date and 25% will vest on
each of the subsequent three anniversaries of the Effective Date.
	 
	 	(b)	 	In the event of the a consummation of the Offering, the Company will recommend
to the WebMD Health Compensation Committee that Executive be granted 40,000 shares of
restricted stock of the Company on the Effective Date (the “New Restricted Stock”),
subject to proportionate adjustment in the number of New Restricted Stock as provided
in Section 5(a) above. The New Restricted Stock will vest and the restrictions thereon
lapse in equal annual installments over four years, commencing on the first anniversary
of the date of grant subject to your continued employment on the applicable dates. The
Restricted Stock will be subject to the terms of a stock plan and a restricted stock
agreement to be entered into between you and the Company, which agreement will be in
substantially the same form provided by the Company to its employees generally.

     6. Termination of Employment. In the event of the termination of your employment by
the Company without Cause or by you for Good Reason (as such terms are defined on Annex A attached
hereto) prior- to the fourth anniversary of the Effective Date, you will be entitled to
(i) continue to receive, as severance, the Base Salary in effect on the date hereof for a period of
one year (the “Severance Period”), (ii) any bonus payable under the last sentence in Section 2(b)
above, and (iii) if you timely elect to continue your health coverage through COBRA, the Company
will pay that portion of the COBRA premium that it would pay if you were an active employee with
the same type of coverage through the Severance Period or, if earlier, until you are eligible for
comparable coverage with a subsequent employer, subject to your execution of a release satisfactory
to the Company (but which will not require release of any Company payments due to you that are
otherwise payable at the date of termination of this Agreement) and your continued compliance with
the Trade Secret & Proprietary Information Agreement. In addition, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason prior to the fourth
anniversary of the Effective Date, 25% of the New Stock Option (if granted) will continue to vest
and remain outstanding as if you remained in the employ of the Company through the vesting date
following the date of termination, subject to your execution of a release satisfactory to the
Company and your continued compliance with the Trade Secret & Proprietary Information Agreement. In
the event of termination of your employment for any other reason, you will receive compensation
earned through the date of termination and your rights with respect to options and restricted stock
will be as specified in the applicable option or restricted stock agreements.

 

 

     7. Restrictive Covenants. You agree that the effectiveness of this Agreement is
contingent upon your execution of, and delivery to the Company of Trade Secret & Proprietary
Information Agreement in the form attached hereto as Annex B.

     8. Conflicting Employment. You agree that, during your employment with the Company,
you will not engage in any other employment, occupation, consulting or other business activity
directly related to the business in which the Company is now involved or becomes involved during
your employment, nor will you engage in any other activities that conflict with your obligations to
the Company. With the prior written approval of the Company, which will not be unreasonably
withheld, you may serve on the Board of Directors of other companies, and provided that such
service does not affect the services to be provided under this Agreement.

     9. At-Will Employment. You acknowledge that your employment with the Company is for an
unspecified duration that constitutes at-will employment, and that either you or the Company can
terminate this relationship at any time, with or without Cause and with or without notice (subject
to the consequences set forth in this agreement).

     10. Effective Date. This Agreement will become effective as of the effectiveness of
the Offering (the “Effective Date”). In the event that the Offering does not occur, this
Agreement will be null and void and will have no force and effect, including, without limitation,
the obligations under Section 5.

     11. General Provisions.

	 	(a)	 	You will be covered by the Company’s director and officer insurance policy to
the same extent as other similarly situated employees of the Company.
	 
	 	(b)	 	This letter agreement and the terms of your employment will be governed by the
laws of New York, applicable to agreements made and to be performed entirely within
such state and the courts sitting in New York, New York shall have exclusive
jurisdiction for the purposes of adjudicating any disputes under this Agreement.
	 
	 	(c)	 	This letter agreement together with the equity plans and agreements referred to
herein and the Trade Secret and Proprietary Agreement attached hereto sets forth the
entire agreement and understanding between the Company and you relating to your
employment and supersedes all prior verbal discussions between us and the Prior
Agreements.
	 
	 	(d)	 	This agreement will be binding upon your heirs, executors, administrators and
other legal representatives and will be for the benefit of the Company and its
permitted successors and assigns
	 
	 	(e)	 	All payments pursuant to this letter will be subject to applicable withholding
taxes.

 

 

	 	(f)	 	This agreement may not be assigned by the Company without your prior written
consent; provided however that this agreement may be assigned by the Company without
your prior written consent to any successor to the business of the Company, by
operation of law, merger or otherwise or to any affiliate of the Company.

     Please acknowledge and confirm your acceptance of this letter by, signing and returning one
copy of this letter agreement and the Trade Secret & Proprietary Information Agreement to Douglas
W. Wamsley, Executive Vice President, General Counsel, WebMD Health Holdings, Inc., 111 Eighth
Avenue, New York, NY 10001.

	 	 	 	 	 
	WebMD Health Holdings, Inc.	 	 
	 
	 	 	 	 
	By
	 	/s/ Douglas W. Wamsley	 	 
	 

	 	 
	 	 

ACCEPTANCE:

     I accept the revised terms of my employment with WebMD Health Holdings, Inc. as set forth
herein. I understand that this letter agreement does not constitute a contract of employment for
any specified period of time, and that either party, with or without Cause and with or without
notice, may terminate my employment relationship (subject to the consequences set forth above).

	 	 	 
	/s/ Steven Zatz

	 	 
	Steven Zatz

	 	 
	 
	 	 
	8/19/05

	 	 
	Date Signed
	 	 

 

 

ANNEX A

“Cause” will mean any of the following:

     (i) your willful failure to perform your duties following written notice from the Company
detailing the specific acts and a thirty (30) day period of time to remedy such failure;

     (ii) any willful misconduct, violence or threat of violence that is injurious to the Company
in a material respect or any misconduct relating to your business affairs, at any time, which will
demonstrably reflect negatively upon the Company or otherwise impair or impede its operations or
reputation in any material respect;

     (iii) your breach of a material Company policy, which breach is not remedied (if susceptible
to remedy) following written notice by the Company detailing the specific breach and a thirty (30)
day period of time to remedy such breach;

     (iv) any material breach by you of this Agreement or the Trade Secret and Proprietary
Information Agreement, which breach is not remedied (if susceptible to remedy) following written
notice by the Company or its designee detailing the specific breach and a thirty (30) day period of
time to remedy such breach;

     (v) your conviction of a felony in respect of a dishonest or fraudulent act or other crime of
moral turpitude.

     “Good Reason” means any of the following conditions or events that remain in effect 30
days after written notice is provided by you to the Company detailing such condition or event (i)
any reduction in your base salary, (ii) a material reduction in your authority with the Company and
(iii) any material breach by the Company of this Agreement.

 

 

ANNEX B

TRADE SECRET AND PROPRIETARY INFORMATION AGREEMENT

     In consideration of WebMD Health Holdings, Inc. (hereinafter referred to as the “Company”)
entering into the Letter Agreement dated July [ ], 2005, I hereby agree as follows:

     1. Confidentiality.

               (a) Trade Secret and Proprietary Information. I understand and acknowledge that,
during the course of my employment arrangement with the Company and as a result of my having
executed this Trade Secret and Proprietary Information Agreement, I will be granted access to
valuable information relating to the Company’s Business (as defined below) that provides the
Company with a competitive advantage, which is not generally known by, nor easily learned or
determined by, persons outside the Company (collectively “Trade Secret an Proprietary
Information”). The term Trade Secret and Proprietary Information will include, but will not be
limited to: (a) specifications, manuals, software in various stages of development; (b) customer
and prospect lists, and details of agreements and communications with customers and prospects; (c)
sales plans and projections, product pricing information, acquisition, expansion, marketing,
financial and other business information and existing and future products and business plans of the
Company; (d) sales proposals, demonstrations systems, sales material; (e) research and development;
(f) computer programs, (g) sources of supply; (h) identity of specialized consultants and
contractors and Trade Secret and Proprietary Information developed by them for the Company; (i)
purchasing, operating and other cost data; (j) special customer needs, cost and pricing data; (k)
patient information; including without limitation Protected Health Information as defined in 45
C.F.R. 164.501 and (l) employee information (including, but not limited to, personnel, payroll,
compensation and benefit data and plans), including all such information recorded in manuals,
memoranda, projections, reports, minutes, plans, drawings, sketches, designs, formula books, data,
specifications, software programs and records, whether or not legended or otherwise identified by
the Company as Trade Secret and Proprietary Information, as well as such information that is the
subject of meetings and discussions and not recorded. Trade Secret and Proprietary Information
will not include such information that I can demonstrate (i) is generally available to the public
(other than as a result of a disclosure by me), (ii) was disclosed to me by a third party under no
obligation to keep such information confidential or (iii) was known by me prior to, and not as a
result of, my employment or anticipated employment with the Company or any of its Affiliates.

               (b) Duty of Confidentiality. I agree at all times, both during and after my employment
with the Company, to hold all of the Company’s Trade Secret and Proprietary Information in a
fiduciary capacity for the benefit of the Company and to safeguard all such Trade Secret and
Proprietary Information. I also agree that I will not directly or indirectly disclose or use any
such Trade Secret and Proprietary Information to any third person or entity outside the Company,
except as may be necessary in the good faith performance of my duties for the Company. I further
agree that, in addition to enforcing this restriction, the Company may have other rights and
remedies under the common law or applicable statutory laws relating to the protection of trade
secrets. Notwithstanding anything in this Agreement to the contrary, I

 

 

understand that I may disclose the Company’s Trade Secret and Proprietary Information to the
extent required by applicable laws or governmental regulations or judicial or regulatory process,
provided that I give the Company prompt notice of any and all such requests for disclosure so that
it has ample opportunity to take all necessary or desired action, to avoid disclosure.

     (c) Unfair Competition. I acknowledge that the Company has a compelling business
interest in preventing unfair competition stemming from the intentional or inadvertent use or
disclosure of the Company’s Trade Secret and Proprietary Information and Company Property.

     (d) Intellectual Property and Inventions. I acknowledge that all developments,
including, without limitation, the creation of new products, conferences, training/seminars,
publications, programs, methods of organizing information, inventions, discoveries, concepts,
ideas, improvements, patents, trademarks, trade names, copyrights, trade secrets, designs, works,
reports, computer software, flow charts, diagrams, procedures, data, documentation, and writings
and applications thereof relating to the past, present, or future business of the Company that I,
alone or jointly with others, may have discovered, conceived, created, made, developed, reduced to
practice, or acquired during my employment with the Company (collectively, “Developments”) are
works made for hire and will remain the sole and exclusive property of the Company, and I hereby
assign to the Company all of my rights, titles, and interest in and to all such Developments, if
any. I agree to disclose to the Company promptly and fully all future Developments and, at any time
upon request and at the expense of the Company, to execute, acknowledge, and deliver to the Company
all instruments that the Company will prepare, to give evidence, and to take any and all other
actions that are necessary or desirable in the reasonable opinion of the Company to enable the
Company to file and prosecute applications for, and to acquire, maintain, and enforce, all letters
patent, trademark registrations, or copyrights covering the Developments in all countries in which
the same are deemed necessary by the Company. All data, memoranda, notes, lists, drawings,
records, files, investor and client/customer lists, supplier lists, and other documentation (and
all copies thereof) made or compiled by me or made available to me concerning the Developments or
otherwise concerning the past, present, or planned business of the Company are the property of the
Company, and will be delivered to the Company immediately upon the termination of my employment
with the Company.

     (e) Competitive Business. For purposes of this Agreement “Competitive Business” will
mean: (i) any enterprise engaged in developing, selling or providing a consumer or physician
Internet healthcare portal or interactive online personal health management products; and (ii) any
enterprise engaged in any other type of business in which the Company or one of its Affiliates is
also engaged, or plans to be engaged, so long as I am directly involved in such business or planned
business on behalf of the Company or one of its Affiliates.

     2. Non-Solicitation of Employees, Customers. In order to protect the Company’s Trade
Secret and Proprietary Information;

     (i) during my employment with the Company and for a period of one year after the termination
of such employment for any reason (the “Restricted Period”), I will not, without the Company’s
express written permission, directly or indirectly solicit, induce, hire, engage, or attempt to
hire or engage any employee or independent contractor of the Company, or in any other way interfere
with the Company’s employment or contractual relations with any of its

 

 

employees or independent contractors, nor will I solicit, induce, hire, engage or attempt to
hire or engage any individual who was an employee of the Company at any time during the one year
period immediately prior to the termination of my employment with the Company

     (ii) during the Restricted Period, I will not, without the Company’s express written
permission, directly or indirectly contact, call upon or solicit, on behalf of a Competitive
Business, any existing or prospective client, or customer of the Company who I serviced, or
otherwise developed a relationship with, as a result of my employment with the Company, nor will I
attempt to divert or take away from the Company the business of any such client or customer.

     3. Restrictions on Competitive Employment. In order to protect the Company’s Trade
Secret and Proprietary Information, during the Restricted Period, I will not (as principal, agent,
employee, consultant, director or otherwise), anywhere in the United States and Canada, directly or
indirectly, without the prior written approval of the Company, engage in, or perform any services
for, a Competitive Business. Notwithstanding the foregoing, I understand that I may have an
interest consisting of publicly traded securities constituting less than 1 percent of any class of
publicly traded securities in any public company engaged in a Competitive Business so long as I am
not employed by and do not consult with, or become a director of or otherwise engage in any
activities for, such company. The Restricted Period will be extended by the length of any period
during which I am in breach of the terms of this paragraph.

     4. Injunctive Remedies. I acknowledge and agree that the restrictions contained in
this Agreement are reasonably necessary to protect the legitimate business interests of the
Company, and that any violation of any of the restrictions will result in immediate and irreparable
injury to the Company for which monetary damages will not be an adequate remedy. I further
acknowledge and agree that if any such restriction is violated, the Company will be entitled to
immediate relief enjoining such violation (including, without limitation, temporary and permanent
injunctions, a decree for specific performance, and an equitable accounting of earnings, profits,
and other benefits arising from such violation) in any court having jurisdiction over such claim,
without the necessity of showing any actual damage or posting any bond or furnishing any other
security, and that the specific enforcement of the provisions of this Agreement will not diminish
my ability to earn a livelihood or create or impose upon me any undue hardship. I also agree that
any request for such relief by the Company will be in addition to, and without prejudice to, any
claim for monetary damages that the Company may elect to assert.

     5. Severability Provision. I acknowledge and agree that the restrictions imposed upon
me by the terms, conditions, and provisions of this Agreement are fair, reasonable, and reasonably
required for the protection of the Company. In the event that any part of this Agreement is deemed
invalid, illegal, or unenforceable, all other terms, conditions, and provisions of this Agreement
will nevertheless remain in full force and effect. In the event that the provisions of any of
Sections l, 2, or 3 of this Agreement relating to the geographic area of restriction, the length of
restriction or the scope of restriction will be deemed to exceed the maximum area, length or scope
that a court of competent jurisdiction would deem enforceable, said area, length or scope will, for
purposes of this Agreement, be deemed to be the maximum area, length of time or scope that such
court would deem valid and enforceable, and that such

 

 

court has the authority under this Agreement to rewrite (or “blue-pencil”) the restriction(s)
at-issue to achieve this intent.

     6. Non-Waiver. Any waiver by the Company of my breach of any term, condition, or
provision of this Agreement will not operate or be construed as a waiver of the Company’s rights
upon any subsequent breach.

     7. Waiver of Jury Trial. TO THE MAXIMUM EXTENT PERMITTED BY LAW, I HEREBY KNOWINGLY,
VOLUNTARILY, AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN CONNECTION WITH ANY LITIGATION
ARISING OUT OF, UNDER, IN CONNECTION WITH, OR IN ANY WAY RELATED TO THIS AGREEMENT. THIS INCLUDES,
WITHOUT LIMITATION, ANY LITIGATION CONCERNING ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENT
(WHETHER VERBAL OR WRITTEN), OR ACTION OF THE COMPANY OR ME, OR ANY EXERCISE BY THE COMPANY OR ME
OF OUR RESPECTIVE RIGHTS UNDER THIS AGREEMENT OR IN ANY WAY RELATING TO THIS AGREEMENT. I FURTHER
ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE COMPANY TO ISSUE AND ACCEPT THIS
AGREEMENT.

     8. Continuation of Employment. This Agreement does not constitute a contract of
employment or an implied promise to continue my employment or status with the Company; nor does
this agreement affect my rights or the rights of the Company to terminate my employment status at
any time with or without cause (subject to the consequences set forth in the Agreement to which
this Annex is attached).

     9. Governing Law. This Agreement will be construed in accordance with and governed
for all purposes by the laws and public policy of the State of New York, without regard to
principles of conflict of laws.

	 	 	 
	/s/ Steven Zatz

	 	 
	 

	 	 
	Steven Zatz

	 	 
	 
	 	 
	/s/ Steven Zatz

	 	 
	 

	 	 
	Witness
	 	 
	 
	 	 
	8/19/05

	 	 
	 

	 	 
	Date
	 	 

	 	 	 	 	 
	 

	 	Address:	 	111 Eighth Ave, NY, NY, 10011

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]